Semaglutide stimulates insulin release in response to glucose. Its prescribing information warns that people taking insulin or a sulfonylurea alongside it may be more likely to develop hypoglycemia [4]. Our guide to how a GLP-1 fits with your existing medicines helps you prepare questions for your visit. If you take either medicine, discuss the combination with the clinician who manages your diabetes.
What the insulin trials measured
The semaglutide trial with automated insulin delivery studied adults with type 1 diabetes in a separate setting. The results below describe different medicines and study populations.
In REIMAGINE 3, adding cagrilintide-semaglutide to basal insulin lowered HbA1c more than placebo in adults with type 2 diabetes. The study reported no severe hypoglycemia [3]. Its group averages cannot determine whether an individual needs a change in insulin dose.
A separate 26-week trial randomized 72 adults with type 1 diabetes and obesity who used automated insulin delivery. The study recorded two severe lows in each group and no reported diabetic ketoacidosis [2]. The trial was too small to establish how frequently rare harms occur.
Low blood sugar after bariatric surgery
Post-bariatric hypoglycemia can occur after meals, in part because the gut releases more GLP-1 and stimulates insulin release. The research on GLP-1 treatment around bariatric surgery addresses weight management, a separate question from treating recurrent lows [1].
What the avexitide studies found
In a phase 2b study with 16 completers, daytime level 2 events measured by continuous glucose monitoring fell by 47.7% and 59.0% during two avexitide regimens. The researchers compared each treatment period with the same participants’ run-in period [1].